In an article titled “Defense Focus in Risperdal Cases May Shift to Causation,” Jim Heller, chair of Cozen O’Connor’s Products Liability Practice Group, discusses the two defenses available to Janssen Pharmaceuticals following verdicts in the first two Risperdal cases: the first for failure to warn and the second for causation. As for whether Janssen should drop its failure to warn defenses entirely, Jim said, “I abandon defenses when the jury gets angry at the evidence … here I don't think that either jury has gotten angry. But I clearly would focus my defense on causation.”

To read the article, click here.